The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Self-blinding citizen science to explore psychedelic microdosing
Open accessAbstract
Microdosing is the practice of regularly using low doses of psychedelic drugs. Anecdotal reports suggest that microdosing enhances well-being and cognition; however, such accounts are potentially biased by the placebo effect. This study used a 'self-blinding' citizen science initiative, where participants were given online instructions on how to incorporate placebo control into their microdosing routine without clinical supervision. The study was completed by 191 participants, making it the largest placebo-controlled trial on psychedelics to-date. All psychological outcomes improved significantly from baseline to after the 4 weeks long dose period for the microdose group; however, the placebo group also improved and no significant between-groups differences were observed. Acute (emotional state, drug intensity, mood, energy, and creativity) and post-acute (anxiety) scales showed small, but significant microdose vs. placebo differences; however, these results can be explained by participants breaking blind. The findings suggest that anecdotal benefits of microdosing can be explained by the placebo effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Szigeti et al. (2021) and Marschall et al. (2021) found no differences in anxiety between microdosing and placebo groups.”
From Psychedelic Microdosing, Mindfulness, and Anxiety: A Cross-Sectional Mediation Study (2023) · cites this paper as Szigeti et al. (2021)
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“therapeutic benefit of low doses of psychedelics remains to be demonstrated in a well-controlled clinical study”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [244]
The cited source says what the claim attributes to it.
In the citing paper
“the data on human psychedelic microdosing are equivocal”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [244]
The cited source says what the claim attributes to it.
In the citing paper
“and another prospective study investigating a general population sample could not attribute changes to MD solely (18).”
From Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study (2023) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development and validation of brief measures of positive and negative affect: The PANAS scales.
Watson, D., Clark, L. A., & Tellegen, A. (1988) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.54.6.1063 · Cited by 32,433
The satisfaction with life scale
Diener, E., Emmons, R. A., Larsen, R. J., & Griffin, S. (1985) · Journal of Personality Assessment · doi:10.1207/s15327752jpa4901_13 · Cited by 31,768
The structure of psychological well-being revisited.
Ryff, C. D., & Keyes, C. L. M. (1995) · Journal of Personality and Social Psychology · doi:10.1037//0022-3514.69.4.719 · Cited by 10,285
An Introduction to the Five‐Factor Model and Its Applications
McCrae, R. R., & John, O. P. (1992) · Journal of Personality · doi:10.1111/j.1467-6494.1992.tb00970.x · Cited by 6,835
The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation
Tennant, R., Hiller, L., Fishwick, R., Platt, S., Joseph, S., Weich, S., Parkinson, J., Secker, J., & Stewart-Brown, S. (2007) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-5-63 · Cited by 5,031
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
Four ways five factors are basic
Costa, P. T., & McCrae, R. R. (1992) · Personality and Individual Differences · doi:10.1016/0191-8869(92)90236-i · Cited by 3,594
State-Trait Anxiety Inventory for Adults
Spielberger, C. D. (2012) · PsycTESTS Dataset · doi:10.1037/t06496-000 · Cited by 3,479
Psychometric properties of the credibility/expectancy questionnaire
Devilly, G. J., & Borkovec, T. D. (2000) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/s0005-7916(00)00012-4 · Cited by 2,295
A new dawn for citizen science
SILVERTOWN, J. W. (2009) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2009.03.017 · Cited by 2,199
Flagged first, then by citations
1 of the 46 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Fadiman J, Krob S. 2017. Microdosing: the phenomenon, research results, and startling surprises. Lecture Presented at the Psychedelic Science 2017 Conference.
Cited by
Sorted by citations
Items 101–190 of 190
Asking questions of psychedelic microdosing
Cameron, L. P. (2021) · eLife · doi:10.7554/elife.66920 · Cited by 6
Myers, M. G., & Toal, C. B. (1995) · PubMed · Cited by 6
Effects of Psychedelic Microdosing on Cognitive Functions: A Systematic Review and Meta-Analysis.
Pinhas, N., Eidlman, N., Barnea, A., & Peled-Avron, L. (2025) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106493 · Cited by 5
Psychedelic Drug Microdosing Practices: A Qualitative Online Exploration
Miller, E., Bojovic, V., Maddren, O., Rao, P., Adesina, D., Petrenko, A., & Ponton, R. (2024) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2024.2304554 · Cited by 5
Acute effects of psilocybin on the dynamics of gaze fixations during visual aesthetic perception
Muller, S. L., Cavanna, F., de la Fuente, L., Bruno, N. M., D’Amelio, T. A., Pallavicini, C., & Tagliazucchi, E. (2025) · Scientific Reports · doi:10.1038/s41598-025-10206-8 · Cited by 5
Jacobs, L., Banbury, S. A., & Lusher, J. M. (2022) · Sexual & Relationship Therapy · doi:10.1080/14681994.2022.2044466 · Cited by 5
Preferences and Support for Psychedelic Policies and Practices Among Those Using Psychedelics
Kruger, D. J., Barron, J., Herberholz, M., & Boehnke, K. F. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2228784 · Cited by 6
Reichelt, A. C., Vermetten, E. H. G. J. M., & Dunkley, B. T. (2023) · Journal of Military Veteran and Family Health · doi:10.3138/jmvfh-2022-0084 · Cited by 6
Vilca-Melendez, S., Uthaug, M. V., & Griffin, J. L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.742856 · Cited by 5
Kiilerich, K. F., Lorenz, J., Scharff, M. B., Speth, N., Brandt, T. G., Czurylo, J., Xiong, M., Jessen, N. S., Casado-Sainz, A., Shalgunov, V., et al. (2023) · doi:10.31219/osf.io/gy6m9 · Cited by 5
Prochazkova, L., Marschall, J., Lippelt, D. P., Schon, N. R., Kuchař, M., & Hommel, B. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110722 · Cited by 4
LSD: Mechanisms and relevance to the treatment of depression
Bouloufa, A., Delcourte, S., Delannay, T., Rovera, R., Lau, T., Moulédous, L., Dkhissi‐Benyahya, O., Guiard, B. P., & Haddjeri, N. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106407 · Cited by 4
Vunduk, J., & Biketova, A. Y. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839167522-00327 · Cited by 4
Prochazkova, L., van Elk, M., Marschall, J., Rifkin, B. D., Fejer, G., Schon, N. R., Fiacchino, D., Kuchař, M., & Hommel, B. (2021) · doi:10.31234/osf.io/emcxw · Cited by 4
Amoruso, E., Terhune, D. B., Kromm, M., Kirker, S. G. B., Muret, D., & Makin, T. R. (2021) · medRxiv · doi:10.1101/2021.12.08.21267128 · Cited by 4
Understanding the Experience of Ketamine-Assisted Therapy and the Importance of Context
Stockwell, G., Hoeh, N. R., Fogarty, F. A., Clayden, C., & Reynolds, L. (2025) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2025.2527299 · Cited by 3
How do psychedelics impact people with a history of non-affective psychosis? A qualitative study
Dourron, H. M., Copes, H., Grossman, D. H., Bradley, M., Nicholas, C. R. N., Turner, J. A., Allen-Clark, G., Gossage, M., & Hendricks, P. S. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1716545 · Cited by 3
How to set up a psychedelic study: Unique considerations for research involving human participants
Glennon, M. J., Bird, C., Yadav, P., Kleine, P., Suseelan, S., Boman-Markaki, C., Kotoula, V., Butler, M., Leech, R., Roseman, L., et al. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106657 · Cited by 5
Classic psychedelics: past uses, present trends, future possibilitiesPreprint
Safron, A., & Johnson, M. W. (2022) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/eys2j · Cited by 3
Petrovitch, D., Victor, S. E., Schmidt, A. T., Schmitz, J. M., Meyer, T. D., Stotts, A. L., & Littlefield, A. K. (2025) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-025-00371-y · Cited by 3
Psychedelics and schizophrenia: A mystery in history
Haden, M., Woods, B., & Paschall, S. A. (2023) · Journal of Psychedelic Studies · doi:10.1556/2054.2023.00277 · Cited by 6
Bobak, L., Dorney, I., Kovacevich, A., & Barnett, B. (2025) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2025.2478097 · Cited by 1
Cohen, R., Bastos, J., Cunha, C., Marguilho, M., Sancho, A. V., Silva, M. J. M., King, F., & Castro-Rodrigues, P. (2026) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2026.02.001 · Cited by 3
Psychedelic-Related Psychosis: From Model Psychosis to Psychotherapy
Bröcker, A., Majić, T., & Montag, C. (2026) · Current topics in behavioral neurosciences · doi:10.1007/7854_2026_613 · Cited by 3
Low-Dose LSD Alters Early and Late Event-Related Potentials to Emotional Faces
Haggarty, C. J., Molla, H. M., Glazer, J. E., Tare, I., Rains, A., de Wit, H., & Lee, R. (2024) · Psychedelic Medicine · doi:10.1089/psymed.2024.0005 · Cited by 2
Towards a cognitive citizen science
den Bussche, E. V., Verhaegen, K. A., Hughes, G., & Reynvoet, B. (2024) · Nature Reviews Psychology · doi:10.1038/s44159-024-00368-z · Cited by 2
Acute Effects and Long-Term Neuropsychological Consequences of Classic Psychedelics Use
Basedow, L. A., & Riemer, T. (2025) · Current topics in behavioral neurosciences · doi:10.1007/7854_2025_600 · Cited by 2
Effect of liner properties on the analysis of lysergic acid diethylamide ( LSD ) analogs
Shuda, S. A. (2025) · Journal of Forensic Sciences · doi:10.1111/1556-4029.70188 · Cited by 2
Die richtige Einstellung : Microdosing und die Medikamentierung des Alltags
Höhne, S. (2023) · KWI-Blog · doi:10.37189/kwi-blog/20230724-0830 · Cited by 2
Psychedelic Microdosing: What Is It Good For?
Bershad, A. K. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.06.021 · Cited by 2
Polito, V., & Liknaitzky, P. (2021) · doi:10.31234/osf.io/edhqz · Cited by 2
Evidence for tolerance in psychedelic microdosing from the self-blinding microdose trialPreprint
Baumann, S., Carhart-Harris, R. L., Nutt, D. J., Erritzøe, D., & Szigeti, B. (2022) · doi:10.31234/osf.io/s4qhf · Cited by 2
Facilitating real-life creative insight through psychedelic virtual realityPreprint
Siimon, T., Tulver, K., Kaup, K., Vasser, M., & Aru, J. (2023) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/zth7f · Cited by 4
Is Microdosing a Placebo?Preprint
Polito, V., & Liknaitzky, P. (2023) · doi:10.31234/osf.io/3ykst · Cited by 2
Turkia, M. (2023) · doi:10.31234/osf.io/dve46 · Cited by 2
Meshkat, S., Fang, H., Sousa-Ho, R., Zeifman, R. J., Dunkley, B. T., Reichelt, A. C., Zhang, Y., Burback, L., Winkler, O., Greenshaw, A. J., et al. (2025) · Psychedelic Medicine · doi:10.1089/psymed.2024.0039 · Cited by 2
Exploring the effects of microdosing on health behaviour change
Prochazkova, L., de Carvalho, L. L., Marrouch, N., Encantado, J., & Teixeira, P. J. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110688 · Cited by 3
Pierre, M. S., Argento, E., Cates, J., Kryskow, P., Harvey, K., Stamets, P. E., Santos-Brault, E., Paschall, S. A., Kuypers, K. P. C., Rootman, J. M., et al. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06913-9 · Cited by 1
Psilocybin-induced modulation of visual salience processing
Muller, S. L., Cavanna, F., de la Fuente, L. A., Bruno, N. M., D’Amelio, T. A., Pallavicini, C., & Tagliazucchi, E. (2025) · Neuroscience of Consciousness · doi:10.1093/nc/niaf060 · Cited by 2
Lodetti, G., Réus, G. Z., & Rico, E. P. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.01.022 · Cited by 1
Beidas, Z., Ragnhildstveit, A., Blackman, A., Anderson, T., Fewster, E. C., Syed, O. A., Sobolenko, V., Kanca, I. K., Jaglinska, M., Son, T., et al. (2026) · BJPsych Open · doi:10.1192/bjo.2025.10968 · Cited by 1
Berg, C. J., McCready, D. M., LoParco, C. R., Schubel, L., Romm, K. F., Thakkar, S., Williams, J., Cavazos‐Rehg, P. A., & Yang, Y. T. (2026) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2026.2685527 · Cited by 1
Özaydın, Y., & Ozaydin, B. C. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261456196 · Cited by 1
Petranker, R., Syed, O. A., Sobolenko, V., Giacobbe, P., Kruger, D. J., Aday, J. S., Lake, S., & Lucas, P. (2026) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2026.105459 · Cited by 1
Golia, K. (2022) · Consciousness Spirituality & Transpersonal Psychology · doi:10.53074/cstp.2022.37 · Cited by 1
Schäfer, T., & Kreuzburg, P. (2023) · European Journal of Psychology Open · doi:10.1024/2673-8627/a000033 · Cited by 2
Do undergraduates’ views of psychedelics relate to the context for psychedelic use?
Petrovitch, D., Allen, J. V., Mitchell, S. M., & Littlefield, A. K. (2025) · Drug Science Policy and Law · doi:10.1177/20503245241308747 · Cited by 2
Tracy, D. K., Joyce, D. W., Albertson, D. N., & Shergill, S. S. (2021) · The British Journal of Psychiatry · doi:10.1192/bjp.2021.41
Reichelt, A. C., & Dunkley, B. T. (2022) · doi:10.31234/osf.io/xa62p · Cited by 1
Fernandes-Nascimento, M. H., Negrão, A. B., Viana-Ferreira, K., Chaves, B. R., & Wang, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-2031631/v1
Psychedelic microdosing hits a rough patch in clinical trials
Plackett, B. (2022) · Nature · doi:10.1038/d41586-022-02876-5
Regulatory, Ethical and Political Challenges of Experimentation with LSD on Human Subjects
Bodnár, J. K., & Peter, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-99680-2_22
Mendelevich, В. D., Konovalova, V. N., Galiullina, G. M., & Galiullina, L. К. (2022) · Neurology Bulletin · doi:10.17816/nb119537
Caldararo, N. (2022) · Springer eBooks · doi:10.1007/978-3-031-13745-7_2
Psychedelics as psychiatric medicines: Current challenges and future prospects
Castle, D. J., Ledwos, N., & Nutt, D. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780192863607.003.0011
Experiencias psicodélicas: fenomenología, potenciales terapéuticos y modelos explicativos
Chernoff, T., Kliger, B., & Venturini, D. H. (2023) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v34i160.463
Tendencias y experiencias del consumo de microdosis de hongos psilocibios en Colombia
Suárez, C., Quintero, S., & Gil, J. M. C. (2023) · Cultura y Droga · doi:10.17151/culdr.2023.28.35.7 · Cited by 1
Investigación sobre microdosificación con hongos psilocibios: un artículo de reflexión
Duque, L. (2023) · Cultura y Droga · doi:10.17151/culdr.2023.28.35.3
Zeifman, R. J. (2024) · doi:10.32920/26052859.v1 · Cited by 1
Microdosing Psychedelics as a Promising New Pharmacotherapeutic
Kuypers, K. P. C. (2024) · Springer eBooks · doi:10.1007/978-3-031-61992-2_26
Totomanova, I., Haijen, E. C. H. M., Hurks, P. P. M., Ramaekers, J. G., & Kuypers, K. P. C. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.03.002
Stadler, F., Saelens, J., Henter, I. D., Rieser, N. M., Greenwald, M. S., Ballard, E. D., Preller, K. H., Zarate, C. A., & Kraus, C. (2025) · medRxiv · doi:10.1101/2025.08.27.25334164
Psychedelic-induced behavioral and developmental effects on zebrafish: a systematic review
de Oliveira, A. L., de Oliveira, D. P., SANTOS, R. G. D., & Hallak, J. E. C. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111534
Murphy, R. J., Wardlaw, M., Smith, T., Noorani, T. N., Evans, W., Reynolds, L., Menkes, D. B., Sumner, R. L., & Muthukumaraswamy, S. D. (2025) · Journal of Humanistic Psychology · doi:10.1177/00221678251382624
Bansal, M., Miller, E., Sumner, R. L., Ponton, R., Muthukumaraswamy, S., & Svirskis, D. M. (2025) · Journal of Chromatographic Science · doi:10.1093/chromsci/bmaf054
Donegan, C. J., Daldegan‐Bueno, D., Sumner, R. L., Forsyth, A., Evans, W., Hoeh, N. R., Sundram, F., Menkes, D. B., Muthukumaraswamy, S. D., & Reynolds, L. (2025) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253251396253
Murphy, R. J., Godfrey, K., Shaw, A. D., Muthukumaraswamy, S., & Sumner, R. L. (2024) · Figshare · doi:10.6084/m9.figshare.25150540
Donegan, C. J., Daldegan‐Bueno, D., Sumner, R. L., Menkes, D., Evans, W. J., Hoeh, N. R., Sundram, F., Reynolds, L., Ponton, R., Cavadino, A., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24257434
Daldegan‐Bueno, D., Donegan, C. J., Forsyth, A., Sumner, R. L., Murphy, R. J., Menkes, D. B., Evans, W. J., Hoeh, N. R., Sundram, F., Reynolds, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26942922
Daldegan‐Bueno, D., Donegan, C. J., Forsyth, A., Sumner, R. L., Murphy, R. J., Menkes, D. B., Evans, W. J., Hoeh, N. R., Sundram, F., Reynolds, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26827416
Daldegan‐Bueno, D., Donegan, C. J., Forsyth, A., Sumner, R. L., Murphy, R. J., Menkes, D. B., Evans, W. J., Hoeh, N. R., Sundram, F., Reynolds, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26827380
Microdoses de psicodélicos no tratamento de transtornos mentais: uma revisão sistemática
Cavalcante, G. J. C. S., Magrini, A. T., Rigelli, R. H., Dendasck, C. V., Dias, C. A. G. D. M., de Araújo, M. H. M., & Fecury, A. A. (2025) · Revista Científica Multidisciplinar Núcleo do Conhecimento · doi:10.32749/nucleodoconhecimento.com.br/saude/microdoses-de-psicodelicos
Miller, C. O. G. (2025) · Springer eBooks · doi:10.1007/978-3-032-13315-1_3
Reward-related neural activity after low doses of LSD in participants with depressed mood
Glazer, J. E., Molla, H. M., Lee, R., Nusslock, R., & de Wit, H. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811251405686
Klepacz, J., Swędrak, R., Swojnóg, M., & Dobrakowska, Z. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.1(49).2026.4582
Halberstadt, A. L., & Young, J. W. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.110972
Meshkat, S., Jha, M. K., & Bhat, V. (2026) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20250043
Carhart-Harris, R. L., Zeifman, R. J., Pasquini, L., Nandi, B., Rohani-Shukla, C., Suseelan, S., Mediano, P. A. M., Rosas, F. C. W., Timmermann, C., Kettner, H., et al. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1875339
THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRY
Osipowska, J., Kwolek, M., Judzińska, A., Piech, B., Sobczyńska, K., Ignarska, J., Terbosh, M., `Mzabi, S. K., Trojanowska, E., & Dubaj, M. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5605
Enriquez‐Geppert, S., Bevers, L., Rosander, A., Fodran, P., & Polito, V. (2026) · Biomolecules · doi:10.3390/biom16070983
Levy‐Cooperman, N., Sellers, E. M., Glue, P., Szeto, I., Brown, D., Jarecki-Smith, J., Tyler, W. J., & McDonnell, M. B. (2026) · medRxiv · doi:10.64898/2026.07.16.26358273
Sams, C. H., Davis, J., Ramdas, A., Delgoda, R., Vidot, D. C., Reid, M., & Haye, W. D. L. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1876189
Meshkat, S., Leung, M., Meshkat, S., Lin, Q., Wijendran, D., Reichelt, A. C., Zhang, Y., Burback, L., Winkler, O., Greenshaw, A. J., et al. (2026) · CNS Drugs · doi:10.1007/s40263-026-01325-5
Polito, V. (2026) · Drug Science Policy and Law · doi:10.1177/20503245261480024
Why taking the trip out of psychedelic medicine is a mistake
Heller, J., & Hendlin, Y. H. (2026) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2026.105487
Psychedelics in the Future of Global Mental Healthcare
Aleksandrova, L. R., Thiessen, K. A., Chen, F. X. F., Phillips, A. G., Schütz, C. G., & Krausz, M. (2026) · Springer eBooks · doi:10.1007/978-3-319-70134-9_174-1
Levy‐Cooperman, N., Sellers, E., Glue, P., Szeto, I., Brown, D., Jarecki-Smith, J., Tyler, W. J., & McDonnell, M. B. (2026) · Pharmaceuticals · doi:10.3390/ph19091496 · Cited by 1
Stadler, F., Saelens, J., Henter, I. D., Rieser, N. M., Greenwald, M. S., Ballard, E. D., Preller, K. H., Zarate, C. A., & Kraus, C. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1843186
Metadata
- Authors
- Szigeti, B., Kartner, L., Blemings, A., Rosas, F., Feilding, A., Nutt, D. J., Carhart-Harris, R. L., & Erritzoe, D.
- Affiliations
- Imperial College London (GB)
- Centre for Psychedelic Research, Imperial College London, London, United Kingdom
- Beckley Foundation (GB)
- Corresponding author
- Szigeti, Balázs
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2021-03-02
- Volume
- 10
- ISSN
- 2050-084X (ISSN-L)
- PMC
- PMC7925122
- OpenAlex
- W3134377893
- Cited by
- 192
- References
- 46
- Citations by year
- 2026: 24 · 2025: 31 · 2024: 34 · 2023: 35 · 2022: 45 · 2021: 22
- FWCI
- 23.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- eLife (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Funders
- National Institute for Health and Care Research (ACF-2013-21-501, CL-2017-21-004)
- Academy of Medical Sciences (SGL019\1063)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Keywords
- psychedelic microdosing, placebo effect, citizen science, subjective well-being, mood, anxiety, creativity, emotional state
- MeSH terms
- Citizen Science, Adult, Affect, Cognition, Creativity, Dose-Response Relationship, Drug, Emotions, Female, Hallucinogens, Humans, Male, Placebo Effect
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review